MedPath

The effect of Omega3 supplementation on uremic pruritus and sleep quality

Not Applicable
Conditions
end stage renal desease.
renal end stage(failer
Registration Number
IRCT2017040433206N1
Lead Sponsor
Vice Chancellor for Research and Technological Sciences anymore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
52
Inclusion Criteria

The inclusion criteria: 1. Age over 18 years 2. patients with chronic renal failure 3. The dialysis time per session, frequency of dialysis per week are the same in both groups. Exclusion criteria: 1. patients younger than 18 years 2. Patients who have used other anti-itch medication and treatment has been effective. 3. The patient's unwillingness to continue the research. 4-malabsorption or any digestive problems (such as chronic diarrhea more than 2 weeks). 5. skin disease that cause itching dermatologist discretion and is not related uremic pruritus. 6. contraindicated antihistamines (blurred vision, glaucoma, prostate, dementia, neurological disorders -Zlany) 7. received drugs or treatments that have the same itch topical emollients, UV rays and effective. 8Sensitivity to omega-3. 9. The patient died

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
remic pruritus. Timepoint: 3 times (baseline, 6 weeks after the intervention, and at the end of the study). Method of measurement: 35/5000 Did you mean: ???????? ???? ????????? Save Reset Itching questionnaire Yvsypvych.
Secondary Outcome Measures
NameTimeMethod
Sleep quality. Timepoint: 3 times (baseline, 6 weeks after the end of the study). Method of measurement: Pittsburgh Sleep Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath